
|Articles|January 1, 2019
- Pharmaceutical Executive-01-01-2019
- Volume 39
- Issue 1
Pharmaceutical Executive, January 2019 Issue (PDF)
Click the title above to open the Pharmaceutical January 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Ipsen’s David Meek: Tasked to Transformover 7 years ago
Drug Research and Review Issues on Radar at FDAover 7 years ago
Finding the Right Digital Health Partnerover 7 years ago
Future Pharma: Data Science as a Strategic Partnerover 7 years ago
Ascending the Uncanny Valley in Healthcareover 7 years ago
Country Report: TurkeyAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
3
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5




